As a consequence an updated version of this grading scale26, and other grading systems have been proposed.27,28 In addition, the lack of a standardized approach to both the grading and management of skin reactions induced by EGFR-targeted therapies has been identified.29 This evidence concerns the gene EGFR and skin reaction.